AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
AEON Biopharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.23−0.00 (-0.43%)
Close on Oct 19, 2026
- Market cap
- $11.67M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.8690 (−79.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $11.67M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -148.31%
Fundamentals
- Net income
- -$54.62M
- EPS, diluted
- -$3.95
- Free cash flow
- -$17.31M
- Book value per share
- -$0.30
- Diluted shares
- 51M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Operating income
-$19.86M
Net income
-$54.62M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months